Clinical Trial

Behavioral Safety and Fentanyl Education: BSAFE

Study acronym: BSAFE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of BSAFE vs attention-control.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-06-10
Trial Details
NCT Number NCT07219082
Lead Sponsor San Francisco Department of Public Health
Collaborators: University of California, San Francisco
Conditions Drug Overdose, Drug Overdose Accidental
Enrollment 160 participants
Start Date 2026-06-15
Primary Completion 2030-01-15 (estimated)
Study Completion 2030-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-09